In Vitro Antibody-Dependent Enhancement Assays Are Insensitive Indicators of in Vivo Vaccine Enhancement of Equine Infectious Anemia Virus

This publication has 54 references indexed in Scilit:

• Studies of Complement-Activating Antibodies in the SIV/Macaque Model of Acute Primary Infection and Vaccine Protection
  AIDS Research and Human Retroviruses, 1995
• Passive Immunization of Rhesus Macaques against SIV Infection and Disease
  AIDS Research and Human Retroviruses, 1995
• The HIV Vaccine Paradox
  Science, 1994
• Interaction of non-antibody factors with HIV in plasma
  AIDS, 1993
• Studies of Antibody-Dependent Enhancement of Human Immunodeficiency Virus (HIV) Type 1 Infection Mediated by Fc Receptors Using Sera from Recipients of a Recombinant gp160 Experimental HIV-1 Vaccine
  The Journal of Infectious Diseases, 1992
• Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals
  AIDS, 1991
• In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV)
  Archiv für die gesamte Virusforschung, 1990
• Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.
  The Journal of Experimental Medicine, 1990
• Modulation of Lentivirus Replication by Antibodies. Non-neutralizing Antibodies to Caprine Arthritis-Encephalitis Virus Enhance Early Stages of Infection in Macrophages, but Do Not Cause Increased Production of Virions
  Journal of General Virology, 1989
• ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
  The Lancet, 1988